Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Verónica, Fabiano"'
Autor:
Pablo Mandó, Verónica Fabiano, Soledad Gomez Guasch, Giuliana Colucci, Rodrigo Sánchez-Bayona, Federico Coló, Martín Loza, Francisco Von Stecher, Mora Amat, Máximo de la Vega, Maria Victoria Costanzo, Adrian Nervo, Jorge Nadal, Reinaldo Chacón, Florencia Perazzo
Publikováno v:
JCO Global Oncology, Iss 10 (2024)
PURPOSEBreast cancer remains a major public health challenge worldwide, and understanding the trends and changes in breast cancer diagnosis and treatment over time is crucial for improving patient outcomes and guiding public health strategies. The Ar
Externí odkaz:
https://doaj.org/article/23ed11c7cae147aa857ca8311f7a2972
Autor:
Verónica Fabiano, Pablo Mandó, Manglio Rizzo, Carolina Ponce, Federico Coló, Martín Loza, Jose Loza, Mora Amat, Daniel Mysler, María Victoria Costanzo, Adrián Nervo, Jorge Nadal, Florencia Perazzo, Reinaldo Chacón
Publikováno v:
JCO Global Oncology, Vol , Iss 6, Pp 639-646 (2020)
PURPOSE Multiple studies have reported that breast cancer in young patients is associated with aggressive characteristics, and it is suggested that prognosis is worse independently of pathologic variables. PATIENTS AND METHODS We performed a retrospe
Externí odkaz:
https://doaj.org/article/bd68930b829f4c82925e350c5f266a10
Autor:
Luisina Bruno, Alexis Ostinelli, Federico Waisberg, Diego Enrico, Carolina Ponce, Sergio Rivero, Albano Blanco, Martín Zarba, Martín Loza, Verónica Fabiano, Mora Amat, María Teresa Pombo, Laura Noro, Matías Chacón, Federico Coló, Reinaldo Chacón, Jorge Nadal, Adrián Nervo, Victoria Costanzo
Publikováno v:
JCO Precision Oncology.
PURPOSE In recent years, unprecedented benefits have been observed with the development of cyclin-dependent kinase (CDK) 4 and 6 inhibitors for the treatment of hormone receptor–positive/human epidermal growth factor receptor 2–negative metastati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::66c6ff7a0c59759b5dcd8f2af975167c
https://doi.org/10.1200/po.21.00140
https://doi.org/10.1200/po.21.00140
Autor:
Jorge Nadal, Carolina Ponce, Daniel C Mysler, Florencia Perazzo, Adrián Nervo, Mora Amat, Verónica Fabiano, Pablo Mandó, Federico Coló, Martín Loza, Jose Loza, MV Costanzo, Reinaldo Chacón, Manglio Rizzo
Publikováno v:
JCO Global Oncology
PURPOSE Multiple studies have reported that breast cancer in young patients is associated with aggressive characteristics, and it is suggested that prognosis is worse independently of pathologic variables. PATIENTS AND METHODS We performed a retrospe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1ffd9d7acb4497c08732a5a3eb8f70a0
https://doi.org/10.1200/jgo.19.00228
https://doi.org/10.1200/jgo.19.00228
Autor:
Carlos Martin Loza, R. D. Chacon, Jose Loza, C Perez de la Puente, Jorge Nadal, Adrian Nervo, Manglio Rizzo, Verónica Fabiano, MV Costanzo, Pablo Mandó, Federico Coló, Carolina Ponce
Publikováno v:
Cancer Research. 78:P6-09
Introduction: ESR1 mutations were described for the first time in 1996 when different tyrosine 537 mutations were found to confer constitutive activation of the receptor, describing this region as a key factor in the ligand regulation of ER transcrip
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2b965140f5894d669ea47fae769c6206
https://doi.org/10.1158/1538-7445.sabcs17-p6-09-09
https://doi.org/10.1158/1538-7445.sabcs17-p6-09-09
Autor:
MT Pombo, MV Costanzo, Carolina Ponce, R. D. Chacon, Adrian Nervo, Pablo Mandó, Verónica Fabiano, C Perez de la Puente, Carlos Martin Loza, M Maino, Jorge Nadal, Manglio Rizzo, Federico Coló
Publikováno v:
Cancer Research. 77:P6-09
Introduction: Breast cancer is the tumor with highest incidence and mortality in women in Argentina. Hormonal receptors (HR) and HER2 are the most important prognostic and predictive factors. It is suggested that estrogen receptors (ER), progesterone
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::55012e830a8cbb079b824ae4fa20b3fd
https://doi.org/10.1158/1538-7445.sabcs16-p6-09-40
https://doi.org/10.1158/1538-7445.sabcs16-p6-09-40
Autor:
Rcm Database Contributors, Carolina Ponce, Carlos Martin Loza, Federico Coló, Jorge Nadal, Anibal Nuñez de Pierro, Verónica Fabiano, MV Costanzo, Reinaldo Chacón, Adrian Nervo, Jose Loza, Pablo Mandó
Background: Nodal staging constitutes an element of great importance in the treatment planning for early breast cancer. The ACOSOG Z0011 trial demonstrated that sentinel lymph node (SLN) biopsy alone results in rates of local control, disease-free su
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7e46c58dc7b9144bc51073ab5835b22e
https://europepmc.org/articles/PMC6381814/
https://europepmc.org/articles/PMC6381814/
Autor:
Jorge Nadal, Victoria Costanzo, Daniel C Mysler, Verónica Fabiano, Reinaldo Chacón, Mora Amat, Adrian Nervo, Federico Coló, Martín Loza, M Maino, Jose Loza
Publikováno v:
Cancer Research. 75:P2-18
Background: Local or regional recurrence in breast cancer is associated with poor prognosis. Mastectomy is the classic indication in these situations. However, second attempts of breast conservation in previously radiated patients with small, histolo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::eee8e4ea4ee5dc0fb8a6295d89d23bf2
https://doi.org/10.1158/1538-7445.sabcs14-p2-18-05
https://doi.org/10.1158/1538-7445.sabcs14-p2-18-05
Autor:
Maria Paula Roberti, Estefanía Paula Juliá, Estrella Mariel Levy, Ariel Podhorzer, Maria Marcela Barrio, Leonardo Fainboim, Federico Coló, Merecedes Maino, Alicia I. Bravo, Jose Loza, Carlos Martin Loza, Yamila S. Rocca, Verónica Fabiano, José Mordoh, Mora Amat
Publikováno v:
European Journal of Immunology. 45:1560-1569
Clinical studies suggest that triple negative breast cancer (TNBC) patients with epidermal growth factor receptor (EGFR)-expressing tumors could benefit from therapy with Cetuximab, which targets EGFR. NK cells are the primary effectors of antibody (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6536338b364256ce1bba61f190748a55
https://doi.org/10.1002/eji.201445353
https://doi.org/10.1002/eji.201445353
Autor:
Maria Paula Roberti, Michele Bianchini, María Betina Pampena, Alicia I. Bravo, Federico Coló, Mora Amat, José Mordoh, Yamila S. Rocca, Reinaldo Chacón, Juan Martín Arriaga, Verónica Fabiano, Jose Loza, Carlos Martin Loza, Estrella Mariel Levy, Maria Marcela Barrio, Enzo Domenichini
Publikováno v:
Breast Cancer Research and Treatment. 136:659-671
Triple-negative breast cancer (TNBC) patients do not benefit from target-specific treatments and is associated with a high relapse rate. Epidermal growth factor receptor is frequently expressed in TNBC and is a candidate for new therapies. In this wo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b6eeb2f71b0b3bc7d9bd1b5228d5bec1
https://doi.org/10.1007/s10549-012-2287-y
https://doi.org/10.1007/s10549-012-2287-y